Abstract
Glomerular diseases, clinically manifesting with proteinuria, hematuria, or azotemia, result from complex disease processes. This complexity is driven by an individual’s genome, unique environmental exposures, and, importantly, through their interaction mediated by innate and adaptive immune responses. The astonishing complexity of each of these aspects is emerging through the lens of new technologies that provide the ability to interrogate human biosamples, including kidney biopsies, in exquisite molecular detail. An individual’s genetic background, their immune responses, and environmental exposures interactively contribute to disease pathogenesis to shape complex disease phenotypes such as glomerulonephritis. In this chapter we review the general pathogenic mechanisms that drive multiple glomerular disease diagnoses and have selected a few specific examples to illustrate how these pathogenic mechanisms influence disease initiation or progression. We have divided the disease mechanisms into the general domains of genetics and innate and adaptive immunity and highlight how genetic background modifies the immune response to cause glomerular diseases in susceptible individuals.
The authors have no conflicts to declare related to this manuscript.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bumgardner GL, Amend WC, Ascher NL, Vincenti FG (1998) Single-center long-term results of renal transplantation for IgA nephropathy. Transplantation 65:1053–1060
Caster DJ, Powell DW, Miralda I, Ward RA, McLeish KR (2017) Re-examining neutrophil participation in GN. J Am Soc Nephrol JASN 28:2275–2289
Cornaby C, Gibbons L, Mayhew V, Sloan CS, Welling A, Poole BD (2015) B cell epitope spreading: mechanisms and contribution to autoimmune diseases. Immunol Lett 163:56–68
Couser WG, Johnson RJ (2014) The etiology of glomerulonephritis: roles of infection and autoimmunity. Kidney Int 86:905–914
Dammacco F, Battaglia S, Gesualdo L, Racanelli V (2013) Goodpasture’s disease: a report of ten cases and a review of the literature. Autoimmun Rev 12:1101–1108
Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329:841–845
Gubler MC (2008) Inherited diseases of the glomerular basement membrane. Nat Clin Pract Nephrol 4:24–37
Gupta S, Kaplan MJ (2016) The role of neutrophils and NETosis in autoimmune and renal diseases. Nat Rev Nephrol 12:402–413
Hildebrandt F (2016) Genetics of kidney diseases. Semin Nephrol 36:472–474
Hinkes BG, Mucha B, Vlangos CN, Gbadegesin R, Liu J, Hasselbacher K, Hangan D, Ozaltin F, Zenker M, Hildebrandt F, Arbeitsgemeinschaft fur Paediatrische Nephrologie Study Group (2007) Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics 119:e907–e919
Hodgin JB, Bitzer M, Wickman L, Afshinnia F, Wang SQ, O’Connor C, Yang Y, Meadowbrooke C, Chowdhury M, Kikuchi M, Wiggins JE, Wiggins RC (2015) Glomerular aging and focal global glomerulosclerosis: a podometric perspective. J Am Soc Nephrol JASN 26:3162
Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA (1999) Phylogenetic perspectives in innate immunity. Science 284:1313–1318
Huber TB, Kottgen M, Schilling B, Walz G, Benzing T (2001) Interaction with podocin facilitates nephrin signaling. J Biol Chem 276:41543–41546
Huber TB, Simons M, Hartleben B, Sernetz L, Schmidts M, Gundlach E, Saleem MA, Walz G, Benzing T (2003) Molecular basis of the functional podocin-nephrin complex: mutations in the NPHS2 gene disrupt nephrin targeting to lipid raft microdomains. Hum Mol Genet 12:3397–3405
Jennette JC, Falk RJ (2014) Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nat Rev Rheumatol 10:463–473
Kiryluk K, Novak J (2014) The genetics and immunobiology of IgA nephropathy. J Clin Invest 124:2325–2332
Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, Mokrzycki MH, Kimmel PL, Limou S, Ahuja TS, Berns JS, Fryc J, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Vlahov D, Pollak M, Winkler CA (2011) APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol JASN 22:2129–2137
Li JN, Jia X, Wang Y, Xie C, Jiang T, Cui Z, Zhao MH (2017) Plasma from patients with anti-glomerular basement membrane disease could recognize microbial peptides. PLoS One 12:e0174553
Magistroni R, D’Agati VD, Appel GB, Kiryluk K (2015) New developments in the genetics, pathogenesis, and therapy of IgA nephropathy. Kidney Int 88:974–989
Malone AF, Phelan PJ, Hall G, Cetincelik U, Homstad A, Alonso AS, Jiang R, Lindsey TB, Wu G, Sparks MA, Smith SR, Webb NJ, Kalra PA, Adeyemo AA, Shaw AS, Conlon PJ, Jennette JC, Howell DN, Winn MP, Gbadegesin RA (2014) Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis. Kidney Int 86:1253–1259
Mariani LH, Pendergraft WF 3rd, Kretzler M (2016) Defining glomerular disease in mechanistic terms: implementing an integrative biology approach in nephrology. Clin J Am Soc Nephrol CJASN 11:2054–2060
Mathern DR, Heeger PS (2015) Molecules great and small: the complement system. Clin J Am Soc Nephrol CJASN 10:1636–1650
Moldoveanu Z, Wyatt RJ, Lee JY, Tomana M, Julian BA, Mestecky J, Huang WQ, Anreddy SR, Hall S, Hastings MC, Lau KK, Cook WJ, Novak J (2007) Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int 71:1148–1154
Niaudet P, Gubler MC (2006) WT1 and glomerular diseases. Pediatr Nephrol 21:1653–1660
O’Toole JF, Bruggeman LA, Madhavan S, Sedor JR (2017) The cell biology of APOL1. Semin Nephrol 37:538–545
Pendergraft WF 3rd, Preston GA, Shah RR, Tropsha A, Carter CW Jr, Jennette JC, Falk RJ (2004) Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med 10:72–79
Pleasant, LDK, SG (2014) Kidney and urinary tract diseases in the newborn. Springer, Berlin
Plotz PH (1983) Autoantibodies are anti-idiotype antibodies to antiviral antibodies. Lancet 2:824–826
Rodrigues JC, Haas M, Reich HN (2017) IgA nephropathy. Clin J Am Soc Nephrol CJASN 12:677–686
Root-Bernstein R, Fairweather D (2014) Complexities in the relationship between infection and autoimmunity. Curr Allergy Asthma Rep 14:407
Roselli S, Gribouval O, Boute N, Sich M, Benessy F, Attie T, Gubler MC, Antignac C (2002) Podocin localizes in the kidney to the slit diaphragm area. Am J Pathol 160:131–139
Salant DJ (2013) Genetic variants in membranous nephropathy: perhaps a perfect storm rather than a straightforward conformeropathy. J Am Soc Nephrol JASN 24:525–528
Savige J (2014) Alport syndrome: its effects on the glomerular filtration barrier and implications for future treatment. J Physiol 592:4013–4023
Schwarz K, Simons M, Reiser J, Saleem MA, Faul C, Kriz W, Shaw AS, Holzman LB, Mundel P (2001) Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Investig 108:1621–1629
Seitz-Polski B, Debiec H, Rousseau A, Dahan K, Zaghrini C, Payre C, Esnault VLM, Lambeau G, Ronco P (2017) Phospholipase A2 receptor 1 epitope spreading at baseline predicts reduced likelihood of remission of membranous nephropathy. J Am Soc Nephrol 29:401
Silva FG, Chander P, Pirani CL, Hardy MA (1982) Disappearance of glomerular mesangial IgA deposits after renal allograft transplantation. Transplantation 33:241–246
Suarez-Fueyo A, Bradley SJ, Klatzmann D, Tsokos GC (2017) T cells and autoimmune kidney disease. Nat Rev Nephrol 13:329–343
Thurman JM, Nester CM (2016) All things complement. Clin J Am Soc Nephrol CJASN 11:1856–1866
Vivante A, Hildebrandt F (2016) Exploring the genetic basis of early-onset chronic kidney disease. Nat Rev Nephrol 12:133–146
Vukmanovic S, Neubert TA, Santori FR (2003) Could TCR antagonism explain associations between MHC genes and disease? Trends Mol Med 9:139–146
Weisheit CK, Engel DR, Kurts C (2015) Dendritic cells and macrophages: sentinels in the kidney. Clin J Am Soc Nephrol CJASN 10:1841–1851
Wiggins RC (2007) The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 71:1205–1214
Wyatt RJ, Julian BA (2013) IgA nephropathy. N Engl J Med 368:2402–2414
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
O’Toole, J.F., Chen, D.P., Sedor, J.R. (2019). Mechanisms of Glomerular Disease. In: Trachtman, H., Herlitz, L., Lerma, E., Hogan, J. (eds) Glomerulonephritis. Springer, Cham. https://doi.org/10.1007/978-3-319-49379-4_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-49379-4_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-49378-7
Online ISBN: 978-3-319-49379-4
eBook Packages: MedicineReference Module Medicine